Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 24.56 CAD 2.8% Market Closed
Market Cap: CA$2.1B

Wall Street
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 24.69 CAD with a low forecast of 19.19 CAD and a high forecast of 31.5 CAD.

Lowest
Price Target
19.19 CAD
22% Downside
Average
Price Target
24.69 CAD
1% Upside
Highest
Price Target
31.5 CAD
28% Upside
Extendicare Inc Competitors:
Price Targets
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
51% Upside
NVT
nVent Electric PLC
10% Upside
TNL
Travel + Leisure Co
13% Upside

Revenue
Forecast

-3% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-3% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 4 years is 11%.

Operating Income
Forecast

-1% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-1% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 4 years is 21%.

Net Income
Forecast

N/A
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
40%
Average Beat
N/A
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
40%
Average Beat

The compound annual growth rate of Extendicare Inc's net income for the next 4 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXE's stock price target?
Price Target
24.69 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 24.69 CAD with a low forecast of 19.19 CAD and a high forecast of 31.5 CAD.

What is Extendicare Inc's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 4 years is 11%.

What is Extendicare Inc's Operating Income forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 4 years is 21%.

What is Extendicare Inc's Net Income forecast?
Projected CAGR
7%

The compound annual growth rate of Extendicare Inc's net income for the next 4 years is 7%.

Back to Top